Marcela Maus: Closing plenary to explore the future of CAR T-Cell therapy in solid tumors
Mediamedic posted on LinkedIn:
”Closing Plenary: The Future of CAR T-Cell Therapy in Solid Tumors
The final plenary of Tandem Meetings 2025, chaired by Dr. Marcela Maus (Massachusetts General Hospital Cancer Center, Harvard Medical School), explored the next frontier in cellular immunotherapy – expanding CAR T-cell therapy from hematologic cancers to solid tumors.
Speakers Dr. Saul Priceman (USC) and Dr. Julia Carnevale (UCSF) presented cutting-edge research on tumor microenvironment modulation, CRISPR-based functional genomics, and next-generation T-cell engineering aimed at overcoming T-cell exhaustion and antigen heterogeneity.
“This closing plenary offers an exciting glimpse into the future of cellular therapeutics,” said Dr. Maus. “We are united in improving the patient experience and curing disease by leveraging cells as medicine.” ”
Find more here.
Stay updated with Hemostasis Today.
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?